ESG Dynamics-Sino Biopharm

Sustainability

Home >Sustainability >ESG Dynamics

3 Products of Sino Biopharm Key Member Company Chia Tai Tianqing Won the Ninth Batch of National Centralized Drug Procurement

Release Date: 2023-11-07

Previous：Sino Biopharm Named "2023 Forbes China ESG Innovative Enterprise"
Next：Sino Biopharm Named to "2023 China's Top 20 Pharmaceutical Listed Companies for ESG Competitiveness" List for the Second Consecutive Year